Silver sulfadiazine is a new topical antimicrobial agent that is used effectively to prevent and treat sepsis in patients with second- and third-degree burns. Because of its low toxicity, relative freedom from complications, and wide spectrum of antimicrobial activity, silver sulfadiazine represents an advance in the pharmacologic management of the burned patient.
(JAMA 230:1184-1185, 1974)
Ballin JC. Evaluation of a New Topical Agent for Burn Therapy: Silver Sulfadiazine (Silvadene). JAMA. 1974;230(8):1184–1185. doi:10.1001/jama.1974.03240080064038
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: